NEW YORK, Oct 31 – Packard BioScience said Tuesday it expects to complete the sale of its Canberra Industries subsidiary, a move that would allow the company to expand its life science business.

Mike Zebarth, a spokesman for Packard BioScience, confirmed that the proceeds from the sale would be used to step up the company’s life science efforts, however, he declined to comment on whether that would be done through acquisitions or organic growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.